Malaria News and Research

Latest Malaria News and Research

Checklist to stay healthy and active during summer season

There are millions of vacation destinations to visit this summer and thousands of sights to see, but there is one surefire way to ruin your trip -- getting sick. Although you may not be thinking about viruses and bacterial infections when you plan your trip, there are a few nasty bugs you should be aware of as you pack your bags.

13 Apr 2010

Automated UV radiation helps decontaminate healthcare-associated pathogens

Attendees of the Fifth Decennial International Conference on Healthcare-Associated Infection were offered a record 37 presentations on the critical role of contaminated environmental surfaces in the transmission of pathogens in healthcare settings.

12 Apr 2010

CoreLab Partners' new logo and brand identity launched

CoreLab Partners, Inc, the recently established global entity resulting from the merger between RadPharm and Medifacts International, has launched a new brand identity to reinforce their capabilities as one of the largest imaging sciences and cardiac safety core labs in the market today.

12 Apr 2010

Clinical and preclinical malaria vaccine data presented at Keystone Symposium

GenVec, Inc. announced that encouraging clinical and preclinical malaria vaccine data were presented at the Keystone Symposium -- Malaria: New Approaches to Understanding Host-Parasite Interactions taking place April 11-16, 2010 in Copper Mountain, Colorado.

12 Apr 2010

Study finds overall increase in developing country domestic health spending, some countries have reduced health budgets as donor funding increases

Researchers on Friday released a study in the Lancet that found while "[m]ost countries in Latin America, Asia and the Middle East doubled their health budgets," countries in sub-Saharan Africa appear to have trimmed their health spending as donors have boosted their health aid, the Associated Press/Washington Post reports.

12 Apr 2010

Cempra to make poster presentations on CEM-101 and CEM-102 at ECCMID 2010

Cempra Pharmaceuticals today announced poster presentations on its novel antibiotic CEM-101, a next-generation macrolide, and CEM-102, the company's proprietary front-loading oral dosing regimen of sodium fusidate, at the 20th European Congress of Clinical Microbiology and Infectious Disease, April 10 to 13, 2010, in Vienna Austria.

12 Apr 2010

We need social security fund on a global scale: The Lancet

We are in need of a social security fund on a global scale. That is what scientists of the Institute of Tropical Medicine Antwerp argue in a Viewpoint in the leading medical journal The Lancet. Such a 'Global Fund for Health' would make the use of international donor money a lot more transparent and efficient.

9 Apr 2010

Cephalon acquires Mepha

Cephalon, Inc. announced that it has today completed its previously announced acquisition of Mepha, the Swiss-based pharmaceutical company. As a result of the acquisition, Mepha is now a wholly-owned subsidiary of Cephalon. The purchase price paid at closing, inclusive of certain closing adjustments, was CHF 662.4 million (or approximately US$615.4 million). The purchase price is also subject to further post-closing working capital and net debt adjustments.

9 Apr 2010

Opinions: Preparing for next flu outbreak; Elections in Zimbabwe; U.S. response to Haiti

Now that concerns about swine flu have eased, "[o]ur fear is that the public and officials will get blase about the next flu outbreak," according to a New York Times editorial. "Efforts to rush vaccine into production did not go well. This dry run should lead health officials to push the vaccine makers even harder to adopt new technologies that can turn out vaccine more quickly.

9 Apr 2010

HSR waiting period for Abbott's tender offer to purchase outstanding shares of Facet Biotech expires

Abbott today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) applicable to Abbott's cash tender offer to purchase all of the outstanding shares of common stock of Facet Biotech Corporation expired last night at 11:59 p.m. Eastern time.

9 Apr 2010

Cempra Pharmaceuticals announces schedule of poster presentations at ECCMID 2010

Cempra Pharmaceuticals today announced its schedule of poster presentations at the 20th European Congress of Clinical Microbiology and Infectious Disease (ECCMID) in Vienna, Austria, on April 10-13, 2010.

8 Apr 2010

UCSF, SEEK Development launch international partnership to improve global health

UCSF and SEEK Development, a global health and development consulting group based in Berlin, Germany, have launched an international partnership that aims to improve global health by helping to turn scientific evidence into policy and action. The Evidence-to-Policy Initiative, or E2Pi, officially launches this week in San Francisco and Berlin, Germany.

7 Apr 2010

StockPreacher.com: GenVec's revenues for 2009 decline by 8%

StockPreacher.com announces an investment report featuring GenVec Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

7 Apr 2010

Crucell, GSK sign agreement to develop 'second generation malaria vaccine'

Crucell, the Dutch biotechnology company, "said on Tuesday it had agreed with Britain's GlaxoSmithKline to jointly develop a malaria vaccine candidate, without disclosing financial details," Reuters reports (Gray-Block, 4/6).

7 Apr 2010

Wall Street Journal examines railway hospital in India

The Wall Street Journal examines Lifeline Express, "the world's first hospital on rails," which is run by Impact India, a group that "initially focused on immunization and prevention of diseases such as polio and malaria." Its success has spread to China and Zimbabwe, where three Lifeline Express trains are operated, and to "hospital river boats based on the India model have been set up to tend to patients in Bangladesh and Cambodia." It has also been used as a model for other health projects in India, according to the newspaper.

3 Apr 2010

RPCI researcher receives grant to explore link between race and breast cancer

Christine Ambrosone, MD, Chair of Cancer Prevention and Control at Roswell Park Cancer Institute (RPCI), has received a grant for $165,000 from the Breast Cancer Research Foundation to study the possible link between race and the possibility of being diagnosed with aggressive breast cancers.

3 Apr 2010

Opinion: Job development for Haiti; NTDs in Africa; U.S. investment in TB

"Even before the earthquake, the Haitian economy was already on shaky ground. There is 70 to 80 percent unemployment in the formal economy. ... U.S. policy helped build this disastrous economy," AFL-CIO Executive Vice President Arlene Holt Baker writes in a Miami Herald opinion piece. Baker says previous employment efforts in Haiti resulted in "stop-gap jobs," which do not provide "employment stability or social protections."

2 Apr 2010

VA may expand list of Gulf War illnesses

The Army Times/Veterans Today: "In a boost for veterans of the 1991 Persian Gulf War and those who have served in recent years in Iraq and Afghanistan, the Veterans Affairs Department has proposed changes to its list of illnesses that are presumed connected to service to include nine infectious diseases."

1 Apr 2010

Also in Global Health News: HIV/AIDS in Central Asia; Nigeria MDGs; Aid transparency; Maternal health in Peru

Aljazerra.net reports on the spread of HIV/AIDS throughout Central Asia along drug routes in the region. The piece examines the lack of information available to the people of Central Asia about HIV prevention strategies and a recent effort among a group of Muslim imams in Tajikistan to educate people about the disease (Andersen, 3/31).

1 Apr 2010

2010 BIO International Convention to discuss issues that impact drug discovery and development

The 2010 BIO International Convention will feature a robust health and medical program highlighting the latest scientific breakthroughs and policy and business development issues that impact drug discovery and development. Hosted by the Biotechnology Industry Organization, the Convention will be held May 3-6, 2010 in Chicago, Ill. at McCormick Place.

31 Mar 2010